Abdominal Aortic Aneurysm Drug Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281354 No. of Pages: 74 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Abdominal Aortic Aneurysm Drug in global, including the following market information:
Global Abdominal Aortic Aneurysm Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Abdominal Aortic Aneurysm Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Abdominal Aortic Aneurysm Drug companies in 2021 (%)
The global Abdominal Aortic Aneurysm Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
BSN-908 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Abdominal Aortic Aneurysm Drug include AstraZeneca Plc, Carolus Therapeutics, Inc., Novartis AG and Vida Therapeutics Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Abdominal Aortic Aneurysm Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Abdominal Aortic Aneurysm Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Abdominal Aortic Aneurysm Drug Market Segment Percentages, by Type, 2021 (%)
BSN-908
Canakinumab
CT-2009
Ticagrelor
Others
Global Abdominal Aortic Aneurysm Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Abdominal Aortic Aneurysm Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Abdominal Aortic Aneurysm Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Abdominal Aortic Aneurysm Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Abdominal Aortic Aneurysm Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Abdominal Aortic Aneurysm Drug revenues share in global market, 2021 (%)
Key companies Abdominal Aortic Aneurysm Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Abdominal Aortic Aneurysm Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
Carolus Therapeutics, Inc.
Novartis AG
Vida Therapeutics Inc.
1 Introduction to Research & Analysis Reports
1.1 Abdominal Aortic Aneurysm Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Abdominal Aortic Aneurysm Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Abdominal Aortic Aneurysm Drug Overall Market Size
2.1 Global Abdominal Aortic Aneurysm Drug Market Size: 2021 VS 2028
2.2 Global Abdominal Aortic Aneurysm Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Abdominal Aortic Aneurysm Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Abdominal Aortic Aneurysm Drug Players in Global Market
3.2 Top Global Abdominal Aortic Aneurysm Drug Companies Ranked by Revenue
3.3 Global Abdominal Aortic Aneurysm Drug Revenue by Companies
3.4 Global Abdominal Aortic Aneurysm Drug Sales by Companies
3.5 Global Abdominal Aortic Aneurysm Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Abdominal Aortic Aneurysm Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Abdominal Aortic Aneurysm Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Abdominal Aortic Aneurysm Drug Players in Global Market
3.8.1 List of Global Tier 1 Abdominal Aortic Aneurysm Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Abdominal Aortic Aneurysm Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Abdominal Aortic Aneurysm Drug Market Size Markets, 2021 & 2028
4.1.2 BSN-908
4.1.3 Canakinumab
4.1.4 CT-2009
4.1.5 Ticagrelor
4.1.6 Others
4.2 By Type - Global Abdominal Aortic Aneurysm Drug Revenue & Forecasts
4.2.1 By Type - Global Abdominal Aortic Aneurysm Drug Revenue, 2017-2022
4.2.2 By Type - Global Abdominal Aortic Aneurysm Drug Revenue, 2023-2028
4.2.3 By Type - Global Abdominal Aortic Aneurysm Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Abdominal Aortic Aneurysm Drug Sales & Forecasts
4.3.1 By Type - Global Abdominal Aortic Aneurysm Drug Sales, 2017-2022
4.3.2 By Type - Global Abdominal Aortic Aneurysm Drug Sales, 2023-2028
4.3.3 By Type - Global Abdominal Aortic Aneurysm Drug Sales Market Share, 2017-2028
4.4 By Type - Global Abdominal Aortic Aneurysm Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Abdominal Aortic Aneurysm Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Abdominal Aortic Aneurysm Drug Revenue & Forecasts
5.2.1 By Application - Global Abdominal Aortic Aneurysm Drug Revenue, 2017-2022
5.2.2 By Application - Global Abdominal Aortic Aneurysm Drug Revenue, 2023-2028
5.2.3 By Application - Global Abdominal Aortic Aneurysm Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Abdominal Aortic Aneurysm Drug Sales & Forecasts
5.3.1 By Application - Global Abdominal Aortic Aneurysm Drug Sales, 2017-2022
5.3.2 By Application - Global Abdominal Aortic Aneurysm Drug Sales, 2023-2028
5.3.3 By Application - Global Abdominal Aortic Aneurysm Drug Sales Market Share, 2017-2028
5.4 By Application - Global Abdominal Aortic Aneurysm Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Abdominal Aortic Aneurysm Drug Market Size, 2021 & 2028
6.2 By Region - Global Abdominal Aortic Aneurysm Drug Revenue & Forecasts
6.2.1 By Region - Global Abdominal Aortic Aneurysm Drug Revenue, 2017-2022
6.2.2 By Region - Global Abdominal Aortic Aneurysm Drug Revenue, 2023-2028
6.2.3 By Region - Global Abdominal Aortic Aneurysm Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Abdominal Aortic Aneurysm Drug Sales & Forecasts
6.3.1 By Region - Global Abdominal Aortic Aneurysm Drug Sales, 2017-2022
6.3.2 By Region - Global Abdominal Aortic Aneurysm Drug Sales, 2023-2028
6.3.3 By Region - Global Abdominal Aortic Aneurysm Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Abdominal Aortic Aneurysm Drug Revenue, 2017-2028
6.4.2 By Country - North America Abdominal Aortic Aneurysm Drug Sales, 2017-2028
6.4.3 US Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.4.4 Canada Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.4.5 Mexico Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Abdominal Aortic Aneurysm Drug Revenue, 2017-2028
6.5.2 By Country - Europe Abdominal Aortic Aneurysm Drug Sales, 2017-2028
6.5.3 Germany Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.5.4 France Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.5.5 U.K. Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.5.6 Italy Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.5.7 Russia Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.5.8 Nordic Countries Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.5.9 Benelux Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Abdominal Aortic Aneurysm Drug Revenue, 2017-2028
6.6.2 By Region - Asia Abdominal Aortic Aneurysm Drug Sales, 2017-2028
6.6.3 China Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.6.4 Japan Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.6.5 South Korea Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.6.6 Southeast Asia Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.6.7 India Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Abdominal Aortic Aneurysm Drug Revenue, 2017-2028
6.7.2 By Country - South America Abdominal Aortic Aneurysm Drug Sales, 2017-2028
6.7.3 Brazil Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.7.4 Argentina Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Abdominal Aortic Aneurysm Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Abdominal Aortic Aneurysm Drug Sales, 2017-2028
6.8.3 Turkey Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.8.4 Israel Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
6.8.6 UAE Abdominal Aortic Aneurysm Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Corporate Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Major Product Offerings
7.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales and Revenue in Global (2017-2022)
7.1.5 AstraZeneca Plc Key News
7.2 Carolus Therapeutics, Inc.
7.2.1 Carolus Therapeutics, Inc. Corporate Summary
7.2.2 Carolus Therapeutics, Inc. Business Overview
7.2.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Major Product Offerings
7.2.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales and Revenue in Global (2017-2022)
7.2.5 Carolus Therapeutics, Inc. Key News
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Abdominal Aortic Aneurysm Drug Major Product Offerings
7.3.4 Novartis AG Abdominal Aortic Aneurysm Drug Sales and Revenue in Global (2017-2022)
7.3.5 Novartis AG Key News
7.4 Vida Therapeutics Inc.
7.4.1 Vida Therapeutics Inc. Corporate Summary
7.4.2 Vida Therapeutics Inc. Business Overview
7.4.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Major Product Offerings
7.4.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales and Revenue in Global (2017-2022)
7.4.5 Vida Therapeutics Inc. Key News
8 Global Abdominal Aortic Aneurysm Drug Production Capacity, Analysis
8.1 Global Abdominal Aortic Aneurysm Drug Production Capacity, 2017-2028
8.2 Abdominal Aortic Aneurysm Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Abdominal Aortic Aneurysm Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Abdominal Aortic Aneurysm Drug Supply Chain Analysis
10.1 Abdominal Aortic Aneurysm Drug Industry Value Chain
10.2 Abdominal Aortic Aneurysm Drug Upstream Market
10.3 Abdominal Aortic Aneurysm Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Abdominal Aortic Aneurysm Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com